Discover the latest advances in cardiovascular treatment — from innovative drugs and devices to cutting-edge procedures. This section highlights new therapies that are reshaping how we prevent and manage heart disease.
Orforglipron heart health is becoming a growing topic in medical news as a new oral GLP-1 receptor agonist shows promising results for weight loss and metabolic improvement. Because obesity, high blood pressure, and type 2 diabetes are major drivers of cardiovascular disease, any new therapy that improves metabolic health could also support a healthier heart. […]
Orforglipron Heart Health: What Patients Should Know Read More »
GLP-1 heart benefits are gaining attention worldwide — and not just for people with diabetes. These medications also help protect the heart and reduce the risk of serious cardiovascular events. In recent years, a class of drugs called GLP-1 receptor agonists has revolutionized diabetes treatment. But the real surprise? These medications also provide major benefits
GLP-1 Heart Benefits: How These Medications Protect Your Heart Read More »
